Adverum Biotechnologies Inc (ADVM)
4.74
+0.04
(+0.85%)
USD |
NASDAQ |
Dec 20, 16:00
4.725
-0.02
(-0.32%)
After-Hours: 20:00
Adverum Biotechnologies Total Liabilities (Quarterly): 90.26M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| EyePoint Pharmaceuticals Inc | 82.18M |
| Cassava Sciences Inc | 57.11M |
| Regenxbio Inc | 217.70M |
| Editas Medicine Inc | 151.93M |
| Apellis Pharmaceuticals Inc | 664.74M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 234.38M |
| Shareholders Equity (Quarterly) | 144.12M |
| Current Ratio | 5.824 |